-
公开(公告)号:US11427593B2
公开(公告)日:2022-08-30
申请号:US16962347
申请日:2019-01-11
申请人: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES , SUZHOU SUPLEAD LIFE SCIENCES CO., LTD.
发明人: Bing Zhou , Cheng Luo , Zizhou Li , Yaxi Yang , Shijie Chen , Hong Ding , Hualiang Jiang , Gang Qiao , Xinjun Wang , Senhao Xiao
IPC分类号: C07D487/04 , A61P35/00 , A61P35/02
摘要: The present invention relates to a bromodomain inhibitor. Provided are a compound represented by general formula I or a pharmaceutically acceptable salt, enantiomer, diastereomer, atropisomer, racemate, polymorph, solvate, or isotopically labeled compound (including deuterium substitution) thereof, a preparation method of the same, a pharmaceutical composition comprising the same, and a pharmaceutical use thereof.
-
公开(公告)号:US20220002278A9
公开(公告)日:2022-01-06
申请号:US17075206
申请日:2020-10-20
申请人: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES , SUZHOU INSTITUTE OF DRUG INNOVATION, SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
发明人: Bing Zhou , Cheng Luo , Hualiang Jiang , Yaxi Yang , Lianghe Mei , Wenchao Lu , Senhao Xiao , Shijie Chen , Shili Wan , Gang Qiao , Rukang Zhang
IPC分类号: C07D413/06 , C07D417/06 , C07D413/14 , C07D491/107 , C07D513/04 , C07D471/04 , C07D495/04 , C07D495/10
摘要: Disclosed is a histone acetyltransferase (HAT) inhibitor. Provided are a compound represented by the general formula I, a pharmaceutically acceptable salt, a stereoisomer, an enantiomer, a diastereoisomer, an atropisomer, a racemate, a polymorph, a solvate or an isotope-labeled compound (including deuterium substitution) thereof, a preparation method therefor, a pharmaceutical composition comprising same and use thereof in the treatment of various HAT-related diseases or conditions.
-
公开(公告)号:US20210101891A1
公开(公告)日:2021-04-08
申请号:US17075206
申请日:2020-10-20
申请人: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES , SUZHOU INSTITUTE OF DRUG INNOVATION, SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENC
发明人: Bing Zhou , Cheng Luo , Hualiang Jiang , Yaxi Yang , Lianghe Mei , Wenchao Lu , Senhao Xiao , Shijie Chen , Shili Wan , Gang Qiao , Rukang Zhang
IPC分类号: C07D413/06 , C07D417/06 , C07D413/14 , C07D491/107 , C07D513/04 , C07D471/04 , C07D495/04 , C07D495/10
摘要: Disclosed is a histone acetyltransferase (HAT) inhibitor. Provided are a compound represented by the general formula I, a pharmaceutically acceptable salt, a stereoisomer, an enantiomer, a diastereoisomer, an atropisomer, a racemate, a polymorph, a solvate or an isotope-labeled compound (including deuterium substitution) thereof, a preparation method therefor, a pharmaceutical composition comprising same and use thereof in the treatment of various HAT-related diseases or conditions.
-
-